Axsome Therapeutics Inc (NASDAQ:AXSM)

Delayed Data
As of Jan 15
 -3.04 / -3.81%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 14 analysts offering 12-month price forecasts for Axsome Therapeutics Inc have a median target of 147.50, with a high estimate of 210.00 and a low estimate of 65.00. The median estimate represents a +91.93% increase from the last price of 76.85.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in Axsome Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -23.08%
Growthannually -36.28%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.